Edition:
United States

Orexo AB (ORX.ST)

ORX.ST on Stockholm Stock Exchange

27.50SEK
26 May 2017
Change (% chg)

0.10kr (+0.36%)
Prev Close
27.40kr
Open
27.40kr
Day's High
27.50kr
Day's Low
27.10kr
Volume
13,198
Avg. Vol
67,009
52-wk High
59.50kr
52-wk Low
26.00kr

ORX.ST

Chart for ORX.ST

About

Orexo AB is a Sweden-based company active within the pharmaceutical industry. It focuses primarily on the development of new, patented drugs by combining documented substances with technologies, and the new treatments for respiratory and inflammatory diseases. The Company has four commercialized products, several projects... (more)

Overall

Beta: 1.89
Market Cap(Mil.): kr949.84
Shares Outstanding(Mil.): 34.54
Dividend: --
Yield (%): --

Financials

  ORX.ST Industry Sector
P/E (TTM): 32.99 14.27 17.41
EPS (TTM): 0.83 -- --
ROI: 4.29 -7.17 -5.42
ROE: 11.32 -6.63 -4.68

BRIEF-Orexo Q1 operating loss narrows

* Says guidance issued in connection with full year report 2016 confirmed Source text for Eikon: Further company coverage: (Stockholm Newsroom)

Apr 20 2017

BRIEF-Orexo files patent infringement lawsuit against Actavis

* Orexo commences patent infringement litigation against Actavis for their generic versions of Suboxone® and Subutex® tablets in the U.S.

Mar 01 2017

BRIEF-Orexo completes bond buyback program

* Says has successfully completed a limited bond buyback program and in total purchased Orexo corporate bonds in the market with a nominal value of MSEK 59 Source text for Eikon: Further company coverage: (Stockholm Newsroom)

Feb 20 2017

BRIEF-Orexo swings to net profit in Q4

* Q4 net earnings msek 33.3 (-51.8) Source text for Eikon: Further company coverage: (Stockholm Newsroom)

Jan 26 2017

More From Around the Web

Earnings vs. Estimates